🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective single-arm, multicenter, phase Ib clinical trial of P...
Status
Terminated
Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Start Date
2022-02-20
Trial ID
NCT05083208
Treatments Being Tested
Ph-like ALL is a recently recognized high-risk subgroup and the optimal the...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564470
Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Status
Unknown
Location
Department of Hematology, Nanfang Hospital
Start Date
2016-02-14
Trial ID
NCT03564704
Treatments Being Tested
This phase II, open-label, dose-escalation study aims to (1) assess the saf...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-09
Trial ID
NCT06858969
Treatments Being Tested
This study is a Phase II clinical trial designed to evaluate the efficacy a...
Status
Recruiting
Location
The Second Hospital of Hebei Medical University
Start Date
2025-09-01
Trial ID
NCT07304232
Treatments Being Tested
This is a prospective, observational, multicenter, cohort study with 400 ne...
Status
Recruiting
Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Start Date
2025-01-01
Trial ID
NCT06779435
Treatments Being Tested
To evaluate the efficacy and safety of chidamide combined with brentuximab ...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-11-01
Trial ID
NCT07074457
ABC study is a phase 2, single-arm, open-label study of Olverembatinib, CD3...
Status
Recruiting
Location
Dept of Hematology, Nanfang Hospital, Southern Medical University
Start Date
2024-02-01
Trial ID
NCT06220487
Treatments Being Tested
To explore the efficacy and safety of Chidamide combined with endocrine for...
Status
Recruiting
Location
天津市肿瘤医院
Start Date
2023-05-16
Trial ID
NCT05890287
Treatments Being Tested
To evaluate the efficacy and safety of bendamustine combined with chidamide...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-11-01
Trial ID
NCT07072221
Treatments Being Tested